Your session is about to expire
← Back to Search
Behavioral Intervention
Text Messaging for Diabetes Control in Homeless Populations
N/A
Recruiting
Research Sponsored by George Washington University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with type 2 DM
Homeless person age ≥ 21
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
Study Summary
This trial looks at how text messages can help people with diabetes who are homeless manage their condition.
Who is the study for?
This trial is for homeless individuals over 21 with type 2 diabetes, who have a recent HbA1c level of at least 8%, and can communicate in English or Spanish. They must be connected to the shelter-clinics involved in the study and able to read/respond to texts. Those with severe uncontrolled illnesses, current severe substance abuse treatment, recent heart attack or stroke, or women who are pregnant/recently gave birth cannot participate.Check my eligibility
What is being tested?
The study is testing whether a strategy using SMS text messages can help manage diabetes better among homeless people. It's a Randomized Controlled Trial (RCT), meaning participants will be randomly assigned to either receive these special texts (intervention) or standard care without extra texting (attention control).See study design
What are the potential side effects?
Since this trial involves sending and receiving text messages as an intervention rather than medication, there are no direct medical side effects associated with it. However, participants may experience stress or frustration if they find managing their condition via texts challenging.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with type 2 diabetes.
Select...
I am 21 or older and currently do not have a home.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Body Weight Changes
Secondary outcome measures
Appointment Adherence
Proportion of Days Covered (PDC)
Summary of Diabetes Self-Care Activities (SDSCA)
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
The intervention (INT) will include 6 months of DM management support via SMS texts including reminders for medication adherence, appointments, and DM self-care activities as well as education, and support.
Group II: ControlPlacebo Group1 Intervention
The control (CL) will receive 6 months of texts for general health promotion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention
2011
Completed Phase 4
~73780
Find a Location
Who is running the clinical trial?
NYU Langone HealthOTHER
1,369 Previous Clinical Trials
840,485 Total Patients Enrolled
18 Trials studying Diabetes
20,252 Patients Enrolled for Diabetes
George Washington UniversityLead Sponsor
243 Previous Clinical Trials
453,674 Total Patients Enrolled
1 Trials studying Diabetes
22 Patients Enrolled for Diabetes
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your most recent HbA1c level is 8% or higher.I can communicate in English or Spanish.I have a severe illness that is not under control.You cannot read or respond to text messages.I have been diagnosed with type 2 diabetes.I am 21 or older and currently do not have a home.I am currently hospitalized for severe substance abuse.I have had a heart attack or stroke in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any spaces still available to join this clinical research project?
"Data hosted on clinicaltrials.gov confirms that this medical research is not accepting new participants as of now. The trial was first posted in December 15th 2022 and last altered November 10th 2022, yet there are still 1171 other studies recruiting patients across the globe."
Answered by AI
Share this study with friends
Copy Link
Messenger